SPOTLIGHT: Merck KGaA blueprints new plant

Germany's Merck KGaA is investing €190 million into a new biopharmaceutical production plant in Darmstadt, the second largest such investment the company has ever made. The plant will make Erbitux, Merck's top-selling drug. Article